Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain

BMC Psychiatry

Table 2 Healthcare utilization among individuals age 15–64 years diagnosed with schizophrenic disorders: 2008–2015

Healthcare utilization	N	Median (IQR)
Overall outpatient visits	799,290	4.5 (2.0–8.2)
Outpatient visits (SD)	666,347	3.8 (1.5–7.0)
^a Specialist visits	312,520	0.96 (0.0–3.6)
^b Length of hospital stay (days)	286,139	4.0 (1.6–9.2)
^c Work absences (days)	292,780	12.5 (3.4–28.8)
Antipsychotics dispensations	2,861,262	15.1 (6.6–28.5)
Antipsychotics dispensations families	N (%)	^d Subjects treated (%)
OA-2nd generation	1,696,420 (59.3)	93.4
LAI-2nd generation	576,913 (20.2)	36.0
OA-1st generation	409,121 (14.3)	33.8
LAI-1st generation	106,103 (3.7)	14.7
Other	72,705 (2.5)	13.3

Abbreviations: IQR Interquartile ratio, LAI Long-acting injection antipsychotics, OA Oral antipsychotic
Median is presented as a rate in person-year
^a Corresponding to mental health specialist visits with the ICD-9-CM code 295.XX
^b Corresponding to 21,095 hospitalizations in the cohort of patients with SD
^c Corresponding to 5445 work absences in the cohort of patients with SD
^d Subjects treated with antipsychotic drugs at some point during the study period

ISSN: 1471-244X